Nottingham University Hospitals NHS Trust
304 capabilities
Verified Sep 2026
One of 2,380 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Nottingham Genomics Laboratory Service, City Hospital Campus, Hucknall Road
Nottingham NG5 1PB , United Kingdom
Nottingham NG5 1PB , United Kingdom
Accreditation
Active
UKAS
8031
nhs.net
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
8031
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDFOther locations
Test Capabilities (304)
| Standard Reference | Description | Category |
|---|---|---|
| Mucin-like glycoproteins – | CA125 | Mucin-like glycoproteins – | CA125 | Clinical Chemistry |
| Tumour marker – pancreatic | CA 19.9 | Tumour marker – pancreatic | CA 19.9 | Clinical Chemistry |
| Effusion/ascitic fluid /CSF, Culture | CYG SOP ARRAY10 | Effusion/ascitic fluid /CSF, Culture | CYG SOP ARRAY10 | Clinical Microbiology |
| Bone marrow / blood Haematological/Oncological disorders | CYG SOP GEN22 | Bone marrow / blood Haematological/Oncological disorders | CYG SOP GEN22 | Hematology |
| Bone marrow / blood Haematological/Oncological disorders | CYG SOP GEN42 | Bone marrow / blood Haematological/Oncological disorders | CYG SOP GEN42 | Hematology |
| Bone marrow / blood Haematological/Oncological disorders | CYG SOP MAL2 | Bone marrow / blood Haematological/Oncological disorders | CYG SOP MAL2 | Hematology |
| Pleural Fluid | ALL and T-ALL Integrated reporting using IN5656 | Pleural Fluid | ALL and T-ALL Integrated reporting using IN5656 | Hematology |
| Pleural Fluid | Chronic Myeloid disorders- Winpath v5. | Pleural Fluid | Chronic Myeloid disorders- Winpath v5. | Hematology |
| Pleural Fluid | MDS | Pleural Fluid | MDS | Hematology |
| A basal epithelial cell | P63 | A basal epithelial cell | P63 | Histopathology / Cytology |
| Acid Fast Bacteria | IN1689 Modified Ziehl-Neelsen | Acid Fast Bacteria | IN1689 Modified Ziehl-Neelsen | Histopathology / Cytology |
| Acid fast bacilli | Ziehl-Neelsen Method - IN1689 | Acid fast bacilli | Ziehl-Neelsen Method - IN1689 | Histopathology / Cytology |
| Acid mucins | AB pH 2.5 Method – IN1691 | Acid mucins | AB pH 2.5 Method – IN1691 | Histopathology / Cytology |
| Acid mucins | Alcian blue – IN1691 | Acid mucins | Alcian blue – IN1691 | Histopathology / Cytology |
| Acid mucins | IN1691 Alcian Blue | Acid mucins | IN1691 Alcian Blue | Histopathology / Cytology |
| Acid mucins, Neutral Mucins & | IN1672 Alcian Blue DPAS | Acid mucins, Neutral Mucins & | IN1672 Alcian Blue DPAS | Histopathology / Cytology |
| Acid mucins, Neutral Mucins & | IN1672 Alcian Blue PAS | Acid mucins, Neutral Mucins & | IN1672 Alcian Blue PAS | Histopathology / Cytology |
| Activated T and B cells | CD31 | Activated T and B cells | CD31 | Histopathology / Cytology |
| Adrenocorticotrophic hormone, | ACTH | Adrenocorticotrophic hormone, | ACTH | Histopathology / Cytology |
| Alpha-1-fetoprotein, classifying | AFP | Alpha-1-fetoprotein, classifying | AFP | Histopathology / Cytology |
| Amyloid | Congo red – IN1673 | Amyloid | Congo red – IN1673 | Histopathology / Cytology |
| Anaplastic large cell | CD34 | Anaplastic large cell | CD34 | Histopathology / Cytology |
| Antibody labels hepatocytes | Hepatocyte | Antibody labels hepatocytes | Hepatocyte | Histopathology / Cytology |
| B cell activator proteins | CD25 | B cell activator proteins | CD25 | Histopathology / Cytology |
| B cells and B Cell neoplasms | CD99 (Mic2) | B cells and B Cell neoplasms | CD99 (Mic2) | Histopathology / Cytology |
| B cells and identification of | CD20 | B cells and identification of | CD20 | Histopathology / Cytology |
| B-cell-specific activator protein | PAX-5 | B-cell-specific activator protein | PAX-5 | Histopathology / Cytology |
| Basal cell compartments of | CK14 | Basal cell compartments of | CK14 | Histopathology / Cytology |
| Basement membrane zone | IN1684 PAS method | Basement membrane zone | IN1684 PAS method | Histopathology / Cytology |
| Basement membranes | IN1679 | Basement membranes | IN1679 | Histopathology / Cytology |
| Basement membranes | IN1679 Jones Basement | Basement membranes | IN1679 Jones Basement | Histopathology / Cytology |
| Basement membranes | Membrane stain | Basement membranes | Membrane stain | Histopathology / Cytology |
| CD1a positive cells in normal | CD1a | CD1a positive cells in normal | CD1a | Histopathology / Cytology |
| CD34 is a useful marker for the | CD23 | CD34 is a useful marker for the | CD23 | Histopathology / Cytology |
| CEA expressing cells | CerbB2 | CEA expressing cells | CerbB2 | Histopathology / Cytology |
| Cell differentiation | Cytology slides | Cell differentiation | Cytology slides | Histopathology / Cytology |
| Cell differentiation | PR1816 – Production of Diagnostic | Cell differentiation | PR1816 – Production of Diagnostic | Histopathology / Cytology |
| Cell differentiation | Papanicalou Stain | Cell differentiation | Papanicalou Stain | Histopathology / Cytology |
| Cell differentiation | Prisma staining machine ME2539 | Cell differentiation | Prisma staining machine ME2539 | Histopathology / Cytology |
| Cells, Fixed Cell Preparations | CYG SOP PND3 | Cells, Fixed Cell Preparations | CYG SOP PND3 | Histopathology / Cytology |
| Classification of B cell | BCL 6 | Classification of B cell | BCL 6 | Histopathology / Cytology |
| Classification of T-Cell | CD3 | Classification of T-Cell | CD3 | Histopathology / Cytology |
| Classification of Wilm’s tumour, | WT1 | Classification of Wilm’s tumour, | WT1 | Histopathology / Cytology |
| Classification of anaplastic large | ALKProtein (CD246) | Classification of anaplastic large | ALKProtein (CD246) | Histopathology / Cytology |
| Classification of melanomas | HMB-45 (DAB chromogen only) | Classification of melanomas | HMB-45 (DAB chromogen only) | Histopathology / Cytology |
| Classification of pituitary | Prolactin | Classification of pituitary | Prolactin | Histopathology / Cytology |
| Complement C4 demonstration | C4D | Complement C4 demonstration | C4D | Histopathology / Cytology |
| Cytokeratin 7&8 on secretory | CAM 5.2 | Cytokeratin 7&8 on secretory | CAM 5.2 | Histopathology / Cytology |
| Cytokeratin – classification of | AE1/AE3 | Cytokeratin – classification of | AE1/AE3 | Histopathology / Cytology |
| Cytotoxic suppressor T Cells | CD8 | Cytotoxic suppressor T Cells | CD8 | Histopathology / Cytology |
| Defects in LAMA2 cause of | Laminin Alpha 2 300 kD | Defects in LAMA2 cause of | Laminin Alpha 2 300 kD | Histopathology / Cytology |
| Demonstrate COX positivity in | Dehydrogenase (SDH) - IN1809 | Demonstrate COX positivity in | Dehydrogenase (SDH) - IN1809 | Histopathology / Cytology |
| Demonstrates glycogenoses | PAS for frozen sections IN2006 | Demonstrates glycogenoses | PAS for frozen sections IN2006 | Histopathology / Cytology |
| Detection of activated platelets, | CD68 | Detection of activated platelets, | CD68 | Histopathology / Cytology |
| Determine HER2 gene | HER2 | Determine HER2 gene | HER2 | Histopathology / Cytology |
| Differential diagnosis of | Dog1 | Differential diagnosis of | Dog1 | Histopathology / Cytology |
| Differential identification of | MLH1 | Differential identification of | MLH1 | Histopathology / Cytology |
| Differential identification of | MSH2 | Differential identification of | MSH2 | Histopathology / Cytology |
| Differential identification of | MSH6 | Differential identification of | MSH6 | Histopathology / Cytology |
| Differential identification of | PMS2 | Differential identification of | PMS2 | Histopathology / Cytology |
| Differentiated neuronal tumours. | NFP | Differentiated neuronal tumours. | NFP | Histopathology / Cytology |
| Differentiation and identification | CK18 | Differentiation and identification | CK18 | Histopathology / Cytology |
| Differentiation between primary | Muc-5AC | Differentiation between primary | Muc-5AC | Histopathology / Cytology |
| Differentiation between | CK5/6 | Differentiation between | CK5/6 | Histopathology / Cytology |
| Differentiation of | PGP | Differentiation of | PGP | Histopathology / Cytology |
| Effusion/ascitic fluid /CSF | CYG SOP CONST1 | Effusion/ascitic fluid /CSF | CYG SOP CONST1 | Histopathology / Cytology |
| Effusion/ascitic fluid /CSF | CYG SOP CONST2 | Effusion/ascitic fluid /CSF | CYG SOP CONST2 | Histopathology / Cytology |
| Effusion/ascitic fluid /CSF | CYG SOP CONST7 | Effusion/ascitic fluid /CSF | CYG SOP CONST7 | Histopathology / Cytology |
| Effusion/ascitic fluid /CSF | CYG SOP CONST8 | Effusion/ascitic fluid /CSF | CYG SOP CONST8 | Histopathology / Cytology |
| Effusion/ascitic fluid /CSF | CYG SOP MAL1 | Effusion/ascitic fluid /CSF | CYG SOP MAL1 | Histopathology / Cytology |
| Effusion/ascitic fluid /CSF | CYG SOP MAL3 | Effusion/ascitic fluid /CSF | CYG SOP MAL3 | Histopathology / Cytology |
| Effusion/ascitic fluid /CSF | CYG SOP PND1 | Effusion/ascitic fluid /CSF | CYG SOP PND1 | Histopathology / Cytology |
| Effusion/ascitic fluid /CSF | CYG SOP PND6 | Effusion/ascitic fluid /CSF | CYG SOP PND6 | Histopathology / Cytology |
| Effusion/ascitic fluid /CSF | SOPs | Effusion/ascitic fluid /CSF | SOPs | Histopathology / Cytology |
| Elastin/collagen/muscle/ RBC | EVG – IN1674 | Elastin/collagen/muscle/ RBC | EVG – IN1674 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Immunostainers – ME633 | Embedded Tissue (FFPE) | Immunostainers – ME633 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | SOPs IN6742 and PR1967 | Embedded Tissue (FFPE) | SOPs IN6742 and PR1967 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | SOPs PR1968 and PR1967 | Embedded Tissue (FFPE) | SOPs PR1968 and PR1967 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | SOPs IN3199 and IN1967 | Embedded Tissue (FFPE) | SOPs IN3199 and IN1967 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | SOPs IN3200 | Embedded Tissue (FFPE) | SOPs IN3200 | Histopathology / Cytology |
| Emery-Dreifuss muscular | Emerin | Emery-Dreifuss muscular | Emerin | Histopathology / Cytology |
| Enzyme Histochemistry | Microscopic examination | Enzyme Histochemistry | Microscopic examination | Histopathology / Cytology |
| Epithelial tissues from simple | MNF116 | Epithelial tissues from simple | MNF116 | Histopathology / Cytology |
| Ewing’s sarcoma marker | CD117 (C kit) | Ewing’s sarcoma marker | CD117 (C kit) | Histopathology / Cytology |
| Expressed in developing brain | OCT 3-4 | Expressed in developing brain | OCT 3-4 | Histopathology / Cytology |
| Expressed in mammary gland | GCDFP15 | Expressed in mammary gland | GCDFP15 | Histopathology / Cytology |
| FFPE Slides prepared in Digital slide scanning for | Hamamatsu slide scanner S60 | FFPE Slides prepared in Digital slide scanning for | Hamamatsu slide scanner S60 | Histopathology / Cytology |
| FFPE Slides prepared in Digital slide scanning for | Lab Halo following SOP IN7236. | FFPE Slides prepared in Digital slide scanning for | Lab Halo following SOP IN7236. | Histopathology / Cytology |
| FFPE Slides prepared in Morphological assessment and | PR1870 – Production of reports – | FFPE Slides prepared in Morphological assessment and | PR1870 – Production of reports – | Histopathology / Cytology |
| FFPE Slides prepared in Morphological assessment and | PR1879 – Skin specimens – | FFPE Slides prepared in Morphological assessment and | PR1879 – Skin specimens – | Histopathology / Cytology |
| FFPE Slides prepared in Morphological assessment and | PR2015 – Gyneacological reporting | FFPE Slides prepared in Morphological assessment and | PR2015 – Gyneacological reporting | Histopathology / Cytology |
| FFPE Slides prepared in Morphological assessment and | PR2017 – Reporting Paediatric GI | FFPE Slides prepared in Morphological assessment and | PR2017 – Reporting Paediatric GI | Histopathology / Cytology |
| FFPE Slides prepared in Morphological assessment and | PR2018 – Placental reporting – | FFPE Slides prepared in Morphological assessment and | PR2018 – Placental reporting – | Histopathology / Cytology |
| FFPE sections | CYG SOP MD25 | FFPE sections | CYG SOP MD25 | Histopathology / Cytology |
| FFPE sections | CYG SOP MD37 | FFPE sections | CYG SOP MD37 | Histopathology / Cytology |
| FFPE sections | CYG SOP MD7 | FFPE sections | CYG SOP MD7 | Histopathology / Cytology |
| FFPE sections | System RSC 16 and 48 systems– | FFPE sections | System RSC 16 and 48 systems– | Histopathology / Cytology |
| Ferric Iron | IN1683 Perls | Ferric Iron | IN1683 Perls | Histopathology / Cytology |
| Ferric iron | Perls’ method – IN1683 | Ferric iron | Perls’ method – IN1683 | Histopathology / Cytology |
| Fibrin,muscle,collagen,RBC | MSB Method – IN1682 | Fibrin,muscle,collagen,RBC | MSB Method – IN1682 | Histopathology / Cytology |
| Fixed and fresh tissue, Examination of tissues | PR3024 | Fixed and fresh tissue, Examination of tissues | PR3024 | Histopathology / Cytology |
| Fixed and fresh tissue, Examination of tissues | PR3926 VIP6TPInst | Fixed and fresh tissue, Examination of tissues | PR3926 VIP6TPInst | Histopathology / Cytology |
| Fixed and fresh tissue, Examination of tissues | Sakura Tissue-Tek 6 embedding | Fixed and fresh tissue, Examination of tissues | Sakura Tissue-Tek 6 embedding | Histopathology / Cytology |
| Fixed and fresh tissue, Examination of tissues | Sakura VIP 6 using SOP – | Fixed and fresh tissue, Examination of tissues | Sakura VIP 6 using SOP – | Histopathology / Cytology |
| Fixed and fresh tissue, Routine staining for | City and QMC Surgical – IN1670 | Fixed and fresh tissue, Routine staining for | City and QMC Surgical – IN1670 | Histopathology / Cytology |
| Fixed and fresh tissue, Routine staining for | Cryostats –Leica CM1950 | Fixed and fresh tissue, Routine staining for | Cryostats –Leica CM1950 | Histopathology / Cytology |
| Fixed and fresh tissue, Routine staining for | Frozen section PR1904 – Frozen | Fixed and fresh tissue, Routine staining for | Frozen section PR1904 – Frozen | Histopathology / Cytology |
| Fixed and fresh tissue, Routine staining for | IN1670 - H&E method instructions | Fixed and fresh tissue, Routine staining for | IN1670 - H&E method instructions | Histopathology / Cytology |
| Fixed and fresh tissue, Routine staining for | IN1810 -H&E Neuro instructions | Fixed and fresh tissue, Routine staining for | IN1810 -H&E Neuro instructions | Histopathology / Cytology |
| Fixed and fresh tissue, Routine staining for | PR1978 – Urgent Neuropathology | Fixed and fresh tissue, Routine staining for | PR1978 – Urgent Neuropathology | Histopathology / Cytology |
| Fixed and fresh tissue, Routine staining for | PR3924 - Production of Frozen | Fixed and fresh tissue, Routine staining for | PR3924 - Production of Frozen | Histopathology / Cytology |
| Fixed and fresh tissue, Routine staining for | PR3943 - Histology Paraffin Wax | Fixed and fresh tissue, Routine staining for | PR3943 - Histology Paraffin Wax | Histopathology / Cytology |
| Fixed and fresh tissue, Routine staining for | QMC – Specialist – IN1810 | Fixed and fresh tissue, Routine staining for | QMC – Specialist – IN1810 | Histopathology / Cytology |
| Fixed and fresh tissue, Routine staining for | Thermo Linistat stainer – ME744 | Fixed and fresh tissue, Routine staining for | Thermo Linistat stainer – ME744 | Histopathology / Cytology |
| Follicular dendritic cells and | CD21 | Follicular dendritic cells and | CD21 | Histopathology / Cytology |
| Follicular lymphoma. Various B | BCL 2 | Follicular lymphoma. Various B | BCL 2 | Histopathology / Cytology |
| Formalin Fixed Paraffin Examination of tissues in order | Manual special stains PR1905 – | Formalin Fixed Paraffin Examination of tissues in order | Manual special stains PR1905 – | Histopathology / Cytology |
| Fresh tissue samples Basophilic and Eosinophilic | Cryostar NX50 Cryostat - ME2561 | Fresh tissue samples Basophilic and Eosinophilic | Cryostar NX50 Cryostat - ME2561 | Histopathology / Cytology |
| Fresh tissue samples Basophilic and Eosinophilic | PR1901 and PR1902 | Fresh tissue samples Basophilic and Eosinophilic | PR1901 and PR1902 | Histopathology / Cytology |
| Frozen sections Lipids | Oil Red O Method – IN1693 | Frozen sections Lipids | Oil Red O Method – IN1693 | Histopathology / Cytology |
| Glandular and transitional | CK7 | Glandular and transitional | CK7 | Histopathology / Cytology |
| Glioma differentiation, low grade | IDH-1 | Glioma differentiation, low grade | IDH-1 | Histopathology / Cytology |
| Glycogen | IN1684 DPAS method | Glycogen | IN1684 DPAS method | Histopathology / Cytology |
| Glycogen | IN1684 PAS method | Glycogen | IN1684 PAS method | Histopathology / Cytology |
| Hep B surface antigen | Shikata’s Orcein Method – IN1686 | Hep B surface antigen | Shikata’s Orcein Method – IN1686 | Histopathology / Cytology |
| ID of B and T cell malignancies | CD5 | ID of B and T cell malignancies | CD5 | Histopathology / Cytology |
| ID of Burkitts’ lymphoma, | CD10 | ID of Burkitts’ lymphoma, | CD10 | Histopathology / Cytology |
| Identification of B-cells in | BOB1 | Identification of B-cells in | BOB1 | Histopathology / Cytology |
| Identification of HHV, the likely | HHV-8 | Identification of HHV, the likely | HHV-8 | Histopathology / Cytology |
| Identification of NK cells, neural | CD56 | Identification of NK cells, neural | CD56 | Histopathology / Cytology |
| Identification of S100-positive | S-100 | Identification of S100-positive | S-100 | Histopathology / Cytology |
| Identification of alpha-1 | Alpha-1anti-Trypsin | Identification of alpha-1 | Alpha-1anti-Trypsin | Histopathology / Cytology |
| Identification of epithelial | CK19 | Identification of epithelial | CK19 | Histopathology / Cytology |
| Identification of lymphatic | D240 (Podoplanin) | Identification of lymphatic | D240 (Podoplanin) | Histopathology / Cytology |
| Identification of mantle cell | CYCLIN D1 | Identification of mantle cell | CYCLIN D1 | Histopathology / Cytology |
| Identification of mucinous | Muc-2 | Identification of mucinous | Muc-2 | Histopathology / Cytology |
| Identification of neuroendocrine | Synaptophysin | Identification of neuroendocrine | Synaptophysin | Histopathology / Cytology |
| Identification of p53 in normal | P53 | Identification of p53 in normal | P53 | Histopathology / Cytology |
| Identification of senile plaques | Beta-Amyloid (βA4) | Identification of senile plaques | Beta-Amyloid (βA4) | Histopathology / Cytology |
| Immunofluorescence | Microscopic examination supported | Immunofluorescence | Microscopic examination supported | Histopathology / Cytology |
| Immunofluorescence | SOP PR3924 | Immunofluorescence | SOP PR3924 | Histopathology / Cytology |
| Inflammatory myofibroblastic | ALK1 (D5F3 Lung) | Inflammatory myofibroblastic | ALK1 (D5F3 Lung) | Histopathology / Cytology |
| Ki-67 antigen in normal and | Ki67 | Ki-67 antigen in normal and | Ki67 | Histopathology / Cytology |
| Labels erythroid cells at almost | Glypican 3 | Labels erythroid cells at almost | Glypican 3 | Histopathology / Cytology |
| Labels follicle stimulating | FSH | Labels follicle stimulating | FSH | Histopathology / Cytology |
| Labels melanocytes and | Melan A (Mart 1) | Labels melanocytes and | Melan A (Mart 1) | Histopathology / Cytology |
| Labels most epithelial cells, | BerEP4 | Labels most epithelial cells, | BerEP4 | Histopathology / Cytology |
| Labels normal T-Cells and | CD2 | Labels normal T-Cells and | CD2 | Histopathology / Cytology |
| Labels normal and neoplastic | LCA (CD45) | Labels normal and neoplastic | LCA (CD45) | Histopathology / Cytology |
| Labels the MUM1 protein, which | MUM1 | Labels the MUM1 protein, which | MUM1 | Histopathology / Cytology |
| Ligand 1 protein in NSCLC | PD-L1 | Ligand 1 protein in NSCLC | PD-L1 | Histopathology / Cytology |
| Low-grade B-cell lymphomas | CD43 | Low-grade B-cell lymphomas | CD43 | Histopathology / Cytology |
| Lung Carcinoma | ROS1 | Lung Carcinoma | ROS1 | Histopathology / Cytology |
| Lymph Node, Solid tissues, analysis and long term storage | CYG SOP CONST13 | Lymph Node, Solid tissues, analysis and long term storage | CYG SOP CONST13 | Histopathology / Cytology |
| Lymphoid restricted | OCT 2 | Lymphoid restricted | OCT 2 | Histopathology / Cytology |
| Melanin | Masson Fontana Method – IN1680 | Melanin | Masson Fontana Method – IN1680 | Histopathology / Cytology |
| Mesothelial cells both benign | HBME1 | Mesothelial cells both benign | HBME1 | Histopathology / Cytology |
| Mononuclear phagocytes | CD79a | Mononuclear phagocytes | CD79a | Histopathology / Cytology |
| Mucins / glycogen | DAB/PAS method – IN1672 | Mucins / glycogen | DAB/PAS method – IN1672 | Histopathology / Cytology |
| Mucins / glycogen | DPAS Method – IN1684 | Mucins / glycogen | DPAS Method – IN1684 | Histopathology / Cytology |
| Muscle, red blood cells, fibrin, | IN1681 | Muscle, red blood cells, fibrin, | IN1681 | Histopathology / Cytology |
| Muscle, red blood cells, fibrin, | IN1681 Trichrome (Blue CS) | Muscle, red blood cells, fibrin, | IN1681 Trichrome (Blue CS) | Histopathology / Cytology |
| Neuroendocrine differentiation | CD63 see NKIC3 | Neuroendocrine differentiation | CD63 see NKIC3 | Histopathology / Cytology |
| Neuronal tumours | NFP | Neuronal tumours | NFP | Histopathology / Cytology |
| Non-acid fast bacteria | Gram – IN2017 | Non-acid fast bacteria | Gram – IN2017 | Histopathology / Cytology |
| Normal B lymphocytes and | CD30 | Normal B lymphocytes and | CD30 | Histopathology / Cytology |
| Normal and abnormal gastric | CK20 | Normal and abnormal gastric | CK20 | Histopathology / Cytology |
| Normal and neoplastic | Calretinin | Normal and neoplastic | Calretinin | Histopathology / Cytology |
| Peripheral blood T cells, NK | CD7 | Peripheral blood T cells, NK | CD7 | Histopathology / Cytology |
| Pleural Fluid | Hemoglobinuria (PNH) | Pleural Fluid | Hemoglobinuria (PNH) | Histopathology / Cytology |
| Pleural Fluid | Lymphoproliferative | Pleural Fluid | Lymphoproliferative | Histopathology / Cytology |
| Pleural Fluid | Mature Lymphoid | Pleural Fluid | Mature Lymphoid | Histopathology / Cytology |
| Pleural Fluid | Paroxysmal Nocturnal | Pleural Fluid | Paroxysmal Nocturnal | Histopathology / Cytology |
| Pneumocystis/Fungi | Grocott method IN1677 | Pneumocystis/Fungi | Grocott method IN1677 | Histopathology / Cytology |
| Pneumocystis/Fungi | IN1677 Modified Grocott (GMS) | Pneumocystis/Fungi | IN1677 Modified Grocott (GMS) | Histopathology / Cytology |
| Positive cells in normal and | Myo D1 | Positive cells in normal and | Myo D1 | Histopathology / Cytology |
| Prostate needle cores | PIN4 | Prostate needle cores | PIN4 | Histopathology / Cytology |
| Reticulin fibres (collagen) | Reticulin Method – IN1685 | Reticulin fibres (collagen) | Reticulin Method – IN1685 | Histopathology / Cytology |
| Reticulin fibres | IN1685 Reticulin method | Reticulin fibres | IN1685 Reticulin method | Histopathology / Cytology |
| Serous Effusions, CSF | IN3790 | Serous Effusions, CSF | IN3790 | Histopathology / Cytology |
| Serous Effusions, CSF | PR1816 | Serous Effusions, CSF | PR1816 | Histopathology / Cytology |
| Slides prepared in house Morphological assessment and | PR1870 – Production of reports – | Slides prepared in house Morphological assessment and | PR1870 – Production of reports – | Histopathology / Cytology |
| Smooth muscle cells | Calponin | Smooth muscle cells | Calponin | Histopathology / Cytology |
| Sputa, Bronchial | Megafuge centrifuge | Sputa, Bronchial | Megafuge centrifuge | Histopathology / Cytology |
| T Cells, oligodendromas and | CD57 | T Cells, oligodendromas and | CD57 | Histopathology / Cytology |
| T and B cells, monocytes, | CD44 | T and B cells, monocytes, | CD44 | Histopathology / Cytology |
| Terminally differentiated plasma | CDX2 | Terminally differentiated plasma | CDX2 | Histopathology / Cytology |
| Thymocytes and T helper cells | CD4 | Thymocytes and T helper cells | CD4 | Histopathology / Cytology |
| Thyroid transcription factor-1 in | TTF1 | Thyroid transcription factor-1 in | TTF1 | Histopathology / Cytology |
| Transmembrane tyrosine kinase | CD138 | Transmembrane tyrosine kinase | CD138 | Histopathology / Cytology |
| Tumour suppressor gene | P16 | Tumour suppressor gene | P16 | Histopathology / Cytology |
| Washings, Bronchial | Thermo cytospin | Washings, Bronchial | Thermo cytospin | Histopathology / Cytology |
| fluid aspirates, tissue | HT20 PR3499 | fluid aspirates, tissue | HT20 PR3499 | Histopathology / Cytology |
| sections on glass slides. morphological and cytological | Manual special stains PR1905 – | sections on glass slides. morphological and cytological | Manual special stains PR1905 – | Histopathology / Cytology |
| Detection of antigens to C1q | C1q | Detection of antigens to C1q | C1q | Immunology / Serology |
| Detection of antigens to C3 | C3 | Detection of antigens to C3 | C3 | Immunology / Serology |
| Amniocytes | Phenol Chloroform | Amniocytes | Phenol Chloroform | Molecular Diagnostics / PCR |
| BRAF | CYG SOP MD45 | BRAF | CYG SOP MD45 | Molecular Diagnostics / PCR |
| Chorionic villi | GEN SOP-1 CVS extraction | Chorionic villi | GEN SOP-1 CVS extraction | Molecular Diagnostics / PCR |
| Cultured cells | GEN SOP-2 Clotted Blood | Cultured cells | GEN SOP-2 Clotted Blood | Molecular Diagnostics / PCR |
| DNA Analysis for clinically significant | 3000 platform including DNA | DNA Analysis for clinically significant | 3000 platform including DNA | Molecular Diagnostics / PCR |
| DNA Analysis for clinically significant | Affymetrix Cytoscan 750k and HD | DNA Analysis for clinically significant | Affymetrix Cytoscan 750k and HD | Molecular Diagnostics / PCR |
| DNA Analysis for clinically significant | CYG SOP ARRAY1 | DNA Analysis for clinically significant | CYG SOP ARRAY1 | Molecular Diagnostics / PCR |
| DNA Analysis for clinically significant | CYG SOP ARRAY11 | DNA Analysis for clinically significant | CYG SOP ARRAY11 | Molecular Diagnostics / PCR |
| DNA Analysis for clinically significant | CYG SOP ARRAY2 | DNA Analysis for clinically significant | CYG SOP ARRAY2 | Molecular Diagnostics / PCR |
| DNA Analysis for clinically significant | CYG SOP ARRAY5 | DNA Analysis for clinically significant | CYG SOP ARRAY5 | Molecular Diagnostics / PCR |
| DNA Analysis for clinically significant | CYG SOP ARRAY6 | DNA Analysis for clinically significant | CYG SOP ARRAY6 | Molecular Diagnostics / PCR |
| DNA Analysis for clinically significant | CYG SOP ARRAY7 | DNA Analysis for clinically significant | CYG SOP ARRAY7 | Molecular Diagnostics / PCR |
| DNA Analysis for clinically significant | CYG SOP ARRAY8 | DNA Analysis for clinically significant | CYG SOP ARRAY8 | Molecular Diagnostics / PCR |
| DNA Analysis for clinically significant | CYG SOP ARRAY9 | DNA Analysis for clinically significant | CYG SOP ARRAY9 | Molecular Diagnostics / PCR |
| DNA Analysis for clinically significant | CYG SOP CONST13 | DNA Analysis for clinically significant | CYG SOP CONST13 | Molecular Diagnostics / PCR |
| DNA Analysis for clinically significant | CYG SOP MAL8 | DNA Analysis for clinically significant | CYG SOP MAL8 | Molecular Diagnostics / PCR |
| DNA Analysis for clinically significant | CYG SOP PND3 | DNA Analysis for clinically significant | CYG SOP PND3 | Molecular Diagnostics / PCR |
| DNA Analysis for clinically significant | CYG SOP PND6 | DNA Analysis for clinically significant | CYG SOP PND6 | Molecular Diagnostics / PCR |
| DNA Analysis for clinically significant | CYG SOP PND8 | DNA Analysis for clinically significant | CYG SOP PND8 | Molecular Diagnostics / PCR |
| DNA extracted in-house from CALR exon 9 indels | Fluorescent PCR, Fragment | DNA extracted in-house from CALR exon 9 indels | Fluorescent PCR, Fragment | Molecular Diagnostics / PCR |
| DNA extracted in-house from JAK2 | CYG SOP MD27 | DNA extracted in-house from JAK2 | CYG SOP MD27 | Molecular Diagnostics / PCR |
| DNA extracted in-house from JAK2 | CYG SOP MD32 | DNA extracted in-house from JAK2 | CYG SOP MD32 | Molecular Diagnostics / PCR |
| DNA extracted in-house from JAK2 | Cyclers | DNA extracted in-house from JAK2 | Cyclers | Molecular Diagnostics / PCR |
| Detection of PML:: RARA t(15;17) | Qualitative reverse transcription | Detection of PML:: RARA t(15;17) | Qualitative reverse transcription | Molecular Diagnostics / PCR |
| Developmental disorders | CYG SOP GEN22 | Developmental disorders | CYG SOP GEN22 | Molecular Diagnostics / PCR |
| Developmental disorders | CYG SOP GEN33 | Developmental disorders | CYG SOP GEN33 | Molecular Diagnostics / PCR |
| Developmental disorders | CYG SOP GEN42 | Developmental disorders | CYG SOP GEN42 | Molecular Diagnostics / PCR |
| Developmental disorders | CYG SOP PND5 | Developmental disorders | CYG SOP PND5 | Molecular Diagnostics / PCR |
| Developmental disorders | Reporting | Developmental disorders | Reporting | Molecular Diagnostics / PCR |
| Effusion/ascitic fluid /CSF | CYG SOP ARRAY3 | Effusion/ascitic fluid /CSF | CYG SOP ARRAY3 | Molecular Diagnostics / PCR |
| Effusion/ascitic fluid /CSF | CYG SOP CONST11 | Effusion/ascitic fluid /CSF | CYG SOP CONST11 | Molecular Diagnostics / PCR |
| Effusion/ascitic fluid /CSF | CYG SOP CONST14 | Effusion/ascitic fluid /CSF | CYG SOP CONST14 | Molecular Diagnostics / PCR |
| Effusion/ascitic fluid /CSF | CYG SOP FISH1 | Effusion/ascitic fluid /CSF | CYG SOP FISH1 | Molecular Diagnostics / PCR |
| Effusion/ascitic fluid /CSF | CYG SOP FISH3 | Effusion/ascitic fluid /CSF | CYG SOP FISH3 | Molecular Diagnostics / PCR |
| Effusion/ascitic fluid /CSF | CYG SOP FISH4 | Effusion/ascitic fluid /CSF | CYG SOP FISH4 | Molecular Diagnostics / PCR |
| Effusion/ascitic fluid /CSF | CYG SOP FISH5 | Effusion/ascitic fluid /CSF | CYG SOP FISH5 | Molecular Diagnostics / PCR |
| Effusion/ascitic fluid /CSF | CYG SOP FISH6 | Effusion/ascitic fluid /CSF | CYG SOP FISH6 | Molecular Diagnostics / PCR |
| Effusion/ascitic fluid /CSF | CYG SOP FISH7 | Effusion/ascitic fluid /CSF | CYG SOP FISH7 | Molecular Diagnostics / PCR |
| Effusion/ascitic fluid /CSF | CYG SOP FISH8 | Effusion/ascitic fluid /CSF | CYG SOP FISH8 | Molecular Diagnostics / PCR |
| Effusion/ascitic fluid /CSF | CYG SOP FISH9 | Effusion/ascitic fluid /CSF | CYG SOP FISH9 | Molecular Diagnostics / PCR |
| Effusion/ascitic fluid /CSF | CYG SOP PND7 | Effusion/ascitic fluid /CSF | CYG SOP PND7 | Molecular Diagnostics / PCR |
| FLT3 (TKD & ITD) | ABI3500XL X2 | FLT3 (TKD & ITD) | ABI3500XL X2 | Molecular Diagnostics / PCR |
| Genomic DNA extracted in house Detection of fragment length size, | 10, FRAX SOP-20 | Genomic DNA extracted in house Detection of fragment length size, | 10, FRAX SOP-20 | Molecular Diagnostics / PCR |
| Genomic DNA extracted in house Detection of fragment length size, | ABI3500xl capillary sequencer x2 | Genomic DNA extracted in house Detection of fragment length size, | ABI3500xl capillary sequencer x2 | Molecular Diagnostics / PCR |
| Genomic DNA extracted in house Detection of fragment length size, | ABI3500xl operation | Genomic DNA extracted in house Detection of fragment length size, | ABI3500xl operation | Molecular Diagnostics / PCR |
| Genomic DNA extracted in house Detection of fragment length size, | Biosystems ABI3500xl capillary | Genomic DNA extracted in house Detection of fragment length size, | Biosystems ABI3500xl capillary | Molecular Diagnostics / PCR |
| Genomic DNA extracted in house Detection of fragment length size, | FRAX SOP-18 | Genomic DNA extracted in house Detection of fragment length size, | FRAX SOP-18 | Molecular Diagnostics / PCR |
| Genomic DNA extracted in house Detection of fragment length size, | HD SOP-9, DM SOP-2, FRAX | Genomic DNA extracted in house Detection of fragment length size, | HD SOP-9, DM SOP-2, FRAX | Molecular Diagnostics / PCR |
| Genomic DNA extracted in house Detection of fragment length size, | KIT SOP), CF SOP-19 (CF Kit | Genomic DNA extracted in house Detection of fragment length size, | KIT SOP), CF SOP-19 (CF Kit | Molecular Diagnostics / PCR |
| Genomic DNA extracted in house Detection of fragment length size, | MAT CON SOP-1 | Genomic DNA extracted in house Detection of fragment length size, | MAT CON SOP-1 | Molecular Diagnostics / PCR |
| Genomic DNA extracted in house Detection of fragment length size, | SOP-19, DMD SOP-26; SMA | Genomic DNA extracted in house Detection of fragment length size, | SOP-19, DMD SOP-26; SMA | Molecular Diagnostics / PCR |
| Genomic DNA extracted in house Detection of known sequence variants | HAEM POL-1, HAEM SOP-1 | Genomic DNA extracted in house Detection of known sequence variants | HAEM POL-1, HAEM SOP-1 | Molecular Diagnostics / PCR |
| Genomic DNA extracted in house Detection of known sequence variants | PCR, GEN SOP-12, GEN SOP-67 | Genomic DNA extracted in house Detection of known sequence variants | PCR, GEN SOP-12, GEN SOP-67 | Molecular Diagnostics / PCR |
| Genomic DNA extracted in house Determination of copy number and | (MLH1 MS-MLPA SOP), GEN | Genomic DNA extracted in house Determination of copy number and | (MLH1 MS-MLPA SOP), GEN | Molecular Diagnostics / PCR |
| Genomic DNA extracted in house Determination of copy number and | Applied Biosystems 3500XL | Genomic DNA extracted in house Determination of copy number and | Applied Biosystems 3500XL | Molecular Diagnostics / PCR |
| Genomic DNA extracted in house Determination of copy number and | SOP), PWAS SOP-15 (PWS/AS | Genomic DNA extracted in house Determination of copy number and | SOP), PWAS SOP-15 (PWS/AS | Molecular Diagnostics / PCR |
| Genomic DNA extracted in house Determination of copy number and | SOP-128 ABI3500XL operation | Genomic DNA extracted in house Determination of copy number and | SOP-128 ABI3500XL operation | Molecular Diagnostics / PCR |
| NPM1 | Analysis to Assess Chimerism | NPM1 | Analysis to Assess Chimerism | Molecular Diagnostics / PCR |
| NPM1 | CYG SOP MD30 NUH Cancer | NPM1 | CYG SOP MD30 NUH Cancer | Molecular Diagnostics / PCR |
| NPM1 | CYG SOP MD33 NUH Cancer | NPM1 | CYG SOP MD33 NUH Cancer | Molecular Diagnostics / PCR |
| NPM1 | CYG SOP MD35 NUH Cancer | NPM1 | CYG SOP MD35 NUH Cancer | Molecular Diagnostics / PCR |
| NPM1 | CYG SOP MD36 NUH Cancer | NPM1 | CYG SOP MD36 NUH Cancer | Molecular Diagnostics / PCR |
| NPM1 | D835 TKD ASSAY | NPM1 | D835 TKD ASSAY | Molecular Diagnostics / PCR |
| NPM1 | Genomics CALR Assay | NPM1 | Genomics CALR Assay | Molecular Diagnostics / PCR |
| NPM1 | Genomics Fragment Analysis on | NPM1 | Genomics Fragment Analysis on | Molecular Diagnostics / PCR |
| NPM1 | Genomics NPM1 Assay | NPM1 | Genomics NPM1 Assay | Molecular Diagnostics / PCR |
| NPM1 | Genomics Use of Microsatellite | NPM1 | Genomics Use of Microsatellite | Molecular Diagnostics / PCR |
| Peripheral Blood | BACC2/3 Nucleon Kit | Peripheral Blood | BACC2/3 Nucleon Kit | Molecular Diagnostics / PCR |
| Peripheral Blood | Extraction | Peripheral Blood | Extraction | Molecular Diagnostics / PCR |
| Peripheral Blood | GEN SOP-109-Chemagic DNA | Peripheral Blood | GEN SOP-109-Chemagic DNA | Molecular Diagnostics / PCR |
| Peripheral Blood | GEN SOP-120 | Peripheral Blood | GEN SOP-120 | Molecular Diagnostics / PCR |
| Peripheral Blood | GEN SOP-130 | Peripheral Blood | GEN SOP-130 | Molecular Diagnostics / PCR |
| Peripheral Blood | Perkin Elmer Chemagic 360-D | Peripheral Blood | Perkin Elmer Chemagic 360-D | Molecular Diagnostics / PCR |
| RNA extracted in-house from Reverse transcription of RNA to cDNA | CYG SOP MD26 | RNA extracted in-house from Reverse transcription of RNA to cDNA | CYG SOP MD26 | Molecular Diagnostics / PCR |
| Saliva | Oragene | Saliva | Oragene | Molecular Diagnostics / PCR |
| See page 1 Chromosome analysis for disorders | CYG SOP CONST10 | See page 1 Chromosome analysis for disorders | CYG SOP CONST10 | Molecular Diagnostics / PCR |
| See page 1 Chromosome analysis for disorders | CYG SOP GEN20 (optichrome) | See page 1 Chromosome analysis for disorders | CYG SOP GEN20 (optichrome) | Molecular Diagnostics / PCR |
| See page 1 Chromosome analysis for disorders | CYG SOP GEN32 | See page 1 Chromosome analysis for disorders | CYG SOP GEN32 | Molecular Diagnostics / PCR |
| See page 1 Chromosome analysis for disorders | CYG SOP PND1 | See page 1 Chromosome analysis for disorders | CYG SOP PND1 | Molecular Diagnostics / PCR |
| See page 1 Chromosome analysis for disorders | Slide Making | See page 1 Chromosome analysis for disorders | Slide Making | Molecular Diagnostics / PCR |
| See page 1 Chromosome analysis for disorders | Solid Tissue – Fibroblast - culture | See page 1 Chromosome analysis for disorders | Solid Tissue – Fibroblast - culture | Molecular Diagnostics / PCR |
| Soft Tissue | GEN SOP-14/29 (nucleon) | Soft Tissue | GEN SOP-14/29 (nucleon) | Molecular Diagnostics / PCR |
| Soft Tissue | GEN SOP-3 Soft tissue | Soft Tissue | GEN SOP-3 Soft tissue | Molecular Diagnostics / PCR |
| Thyroid cancers, Cholangiocarcinoma | CYG SOP MD55, CYG SOP MD56 | Thyroid cancers, Cholangiocarcinoma | CYG SOP MD55, CYG SOP MD56 | Molecular Diagnostics / PCR |
| Uncultured amniocytes and DNA extraction, quantification and | GEN SOP-79 | Uncultured amniocytes and DNA extraction, quantification and | GEN SOP-79 | Molecular Diagnostics / PCR |
| Uncultured amniocytes and DNA extraction, quantification and | Spectrophotometer and Qubit 3.0 | Uncultured amniocytes and DNA extraction, quantification and | Spectrophotometer and Qubit 3.0 | Molecular Diagnostics / PCR |
| Uncultured amniocytes and | Extractor | Uncultured amniocytes and | Extractor | Molecular Diagnostics / PCR |
| Uncultured amniocytes and | GEN SOP-121 Maxwell amnio CVS | Uncultured amniocytes and | GEN SOP-121 Maxwell amnio CVS | Molecular Diagnostics / PCR |
| and received as primary samples | ABI3500xl operation | and received as primary samples | ABI3500xl operation | Molecular Diagnostics / PCR |
| and received as primary samples | Applied Biosystems 3500xl | and received as primary samples | Applied Biosystems 3500xl | Molecular Diagnostics / PCR |
| BCR-ABL1 p210 major (e13a2 and | Applied Biosystems 7500 Fast | BCR-ABL1 p210 major (e13a2 and | Applied Biosystems 7500 Fast | Other |
| BCR-ABL1 p210 major (e13a2 and | BCRQ results according to the | BCR-ABL1 p210 major (e13a2 and | BCRQ results according to the | Other |
| BCR-ABL1 p210 major (e13a2 and | CYG SOP MD41 | BCR-ABL1 p210 major (e13a2 and | CYG SOP MD41 | Other |
| BCR-ABL1 p210 major (e13a2 and | CYG SOP MD42 | BCR-ABL1 p210 major (e13a2 and | CYG SOP MD42 | Other |
| BCR-ABL1 p210 major (e13a2 and | International Standard | BCR-ABL1 p210 major (e13a2 and | International Standard | Other |
| BCR-ABL1 p210 major (e13a2 and | Real-Time qPCR system reporting | BCR-ABL1 p210 major (e13a2 and | Real-Time qPCR system reporting | Other |
| DNA extracted in-house from JAK2 | Allele Specific PCR and | DNA extracted in-house from JAK2 | Allele Specific PCR and | Other |
| FFPE | GEN SOP 87 (paraffin –embedded | FFPE | GEN SOP 87 (paraffin –embedded | Other |
| Fixed and fresh tissue, Examination of tissues | IN6820, IN6837, IN7106, and | Fixed and fresh tissue, Examination of tissues | IN6820, IN6837, IN7106, and | Other |
| Fresh tissue samples Basophilic and Eosinophilic | Mohs) using Leica CM1950 | Fresh tissue samples Basophilic and Eosinophilic | Mohs) using Leica CM1950 | Other |
| Genomic DNA extracted in house Detection of fragment length size, | Amplidex Asuragen FMR1 kit for | Genomic DNA extracted in house Detection of fragment length size, | Amplidex Asuragen FMR1 kit for | Other |
| Genomic DNA extracted in house Detection of known sequence variants | 13 (BRCA1 exon 13 duplication | Genomic DNA extracted in house Detection of known sequence variants | 13 (BRCA1 exon 13 duplication | Other |
| Genomic DNA extracted in house Detection of known sequence variants | GEN SOP-67 (agarose gel | Genomic DNA extracted in house Detection of known sequence variants | GEN SOP-67 (agarose gel | Other |
| Genomic DNA extracted in house Determination of copy number and | MS-MLPA SOP), HNPCC SOP-10 | Genomic DNA extracted in house Determination of copy number and | MS-MLPA SOP), HNPCC SOP-10 | Other |
| NPM1 | CYG SOP MD43 FLT-3 ITD AND | NPM1 | CYG SOP MD43 FLT-3 ITD AND | Other |
| Saliva | GEN SOP-81 Saliva (Oragene | Saliva | GEN SOP-81 Saliva (Oragene | Other |
| and received as primary samples | Analysis), GEN SOP-128 | and received as primary samples | Analysis), GEN SOP-128 | Other |
| and received as primary samples | SOP-3 (QF-PCR preparation and | and received as primary samples | SOP-3 (QF-PCR preparation and | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.